Argpyrimidine, a methylglyoxal-derived advanced glycation end-product in familial amyloidotic polyneuropathy

Biochemical Journal

Volumn 385, Issue 2, 2005, Pages 339-345

  Gomes, Ricardo ^a   Sousa Silva, Marta ^a   Quintas, Alexandre ^a   Cordeiro, Carlos ^a   Freire, António ^b   Pereira, Paulino ^b   Martins, Américo ^b   Monteiro, Estela ^b   Barroso, Eduardo ^b   Ponces Freire, Ana ^a  

^a UNIVERSITY OF LISBON   (Portugal)

^b HOSPITAL CURRY CABRAL   (Portugal)

Author keywords

Advanced glycation end product (AGE); Amyloid; Argpyrimidine; Familial amyloidotic polyneuropathy (FAP); Glycation; Methylglyoxal

Indexed keywords

AMINO ACIDS; CELL CULTURE; CHROMATOGRAPHY; MUTAGENS; PROTEINS; TOXICITY;

AMINO ACID ANALYSIS; ARGPYRIMIDINE; FAMILIAL AMYLOIDOTIC POLYNEUROPATHY (FAP); TRANSTHYRETIN;

DISEASES;

ADVANCED GLYCATION END PRODUCT; AMYLOID; ANILINE DERIVATIVE; ARGPYRIMIDINE; DABSYL CHLORIDE; METHYLGLYOXAL; PREALBUMIN; SERUM ALBUMIN; UNCLASSIFIED DRUG;

ADULT; AMINO ACID ANALYSIS; AMYLOIDOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DISSOCIATION; EXTRACELLULAR SPACE; FAMILIAL AMYLOID POLYNEUROPATHY; FATALITY; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; NEUROPATHOLOGY; ONSET AGE; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FOLDING; PROTEIN GLYCOSYLATION; PROTEIN STABILITY; PROTEIN STRUCTURE;

ADIPOSE TISSUE; ADULT; AMYLOID; AMYLOID NEUROPATHIES, FAMILIAL; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MAILLARD REACTION; MALE; ORNITHINE; PYRIMIDINES; PYRUVALDEHYDE;

EID: 19944432234     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20040833     Document Type: Article

References (51)

1. Costa, P. P., Figueira, A. S. and Bravo, F. R. (1978) Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy. Proc. Natl. Acad. Sci. U.S.A. 75, 4499-4503
2. Andrade, C. (1952) A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 75, 408-427
3. Ghiso, J., Wisniewski, T. and Frangione, B. (1994) Unifying features of systemic and cerebral amyloidosis. Mol. Neurobiol. 8, 49-64
4. Kanai, M., Raz, A. and Goodman, D. S. (1968) Retinol-binding protein: the transport protein for vitamin A in human plasma. J. Clin. Invest. 47, 2025-2044
5. Raz, A., Shiratori, T. and Goodman, D. S. (1970) Studies on the protein-protein and protein-ligand interactions involved in retinol transport in plasma. J. Biol. Chem. 245, 1903-1912
6. Saraiva, M. J., Birken, S., Costa, P. P. and Goodman, D. S. (1984) Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type: definition of molecular abnormality in transthyretin (prealbumin). J. Clin. Invest. 74, 104-119
7. Benson, M. D. (1989) Familial amyloidotic polyneuropathy. Trends Neurosci. 12, 88-92
8. Westermark, P., Sletten, K., Johansson, B. and Cornwell, 3rd, G. G. (1990) Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc. Natl. Acad. Sci. U.S.A. 87, 2843-2845
9. Sousa, M. M., Van, S., Fernandes, R., Guimarāes, A., Stern, D. and Saraiva, M. J. (2001) Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways. J. Neurosci. 21, 7576-7586
10. Du Van, S., Zhu, H., Fu, J., Van, S. F., Roher, A., Tourtellotte, W. W., Rajavashisth, T., Chen, X., Godman, G. C., Stern, D. and Schmidt, A. M. (1997) Amyloid-β peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 94, 5296-5301
11. Vitek, M. P., Bhattacharya, K., Glendening, J. M., Stopa, E., Vlassara, H., Bucala, R., Manogue, K. and Cerami, A. (1994) Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 91, 4766-4770
12. Yan, S. D., Chen, X., Schmidt, A. M., Brett, J., Godman, G., Zou, Y. S., Scott, C. W., Caputo, C., Frappier, T. and Smith, M. A. (1994) Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc. Natl. Acad. Sci. U.S.A. 91, 7787-7791
13. 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis- associated amyloidosis: induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-α and interleukin-1. J. Clin. Invest. 93, 521-528
14. ε-(Carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem. J. 324, 565-570
15. Frye, E. B., Degenhardt, T. P., Thorpe, S. R. and Baynes, J. W. (1998) Role of the Maillard reaction in aging of tissue proteins: advanced glycation end product-dependent increase in imidazolium cross-links in human lens proteins. J. Biol. Chem. 273, 18714-18719
16. Riley, M. L. and Harding, J. J. (1995) The reaction of methylglyoxal with human and bovine lens proteins. Biochim. Biophys. Acta 1270, 36-43
17. Iversen, L. L., Mortishire-Smith, R. J., Pollack, S. J. and Shearman, M. S. (1995) The toxicity in vitro of β-amyloid protein. Biochem. J. 311, 1-16
18. Monnier, V. M. and Cerami, A. (1981) Nonenzymatic browning in vivo: possible process for aging of long-lived proteins. Science 211, 491-493
19. Dyer, D. G., Blackledge, J. A., Thorpe, S. R. and Baynes, J. W. (1991) Formation of pentosidine during nonenzymatic browning of proteins by glucose: identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. J. Biol. Chem. 266, 11654-11660
20. Neeper, M., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y. C., Elliston, K., Stern, D. and Shaw, A. (1992) Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 267, 14998-15004
21. Schmidt, A. M., Vianna, M., Gerlach, M., Brett, J., Ryan, J., Kao, J., Esposito, C., Hegarty, H., Hurley, W. and Clauss, M. (1992) Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J. Biol. Chem. 267, 14987-14997
22. 1as as a common signaling target of reactive free radicals and cellular redox stress. J. Biol. Chem. 270, 21195-21198
23. Westwood, M. E., Argirov, O. K., Abordo, E. A. and Thornalley, P. J. (1997) Methylglyoxal-modified arginine residues - a signal for receptor-mediated endocytosis and degradation of proteins by monocytic THP-1 cells. Biochim. Biophys. Acta 1356, 84-94
24. Shipanova, I. N., Glomb, M. A. and Nagaraj, R. H. (1997) Protein modification by methylglyoxal: chemical nature and synthetic mechanism of a major fluorescent adduct. Arch. Biochem. Biophys. 344, 29-36
25. Shibata, N., Hirano, A., Hedley-Whyte, E. T., Dal Canto, M. C., Nagai, R., Uchida, K., Horiuchi, S., Kawaguchi, M., Yamamoto, T. and Kobayashi, M. (2002) Selective formation of certain advanced glycation end products in spinal cord astrocytes of humans and mice with superoxide dismutase-1 mutation. Acta Neuropathol. (Berlin) 104, 171-178
26. Oya, T., Hattori, N., Mizuno, Y., Miyata, S., Maeda, S., Osawa, T. and Uchida, K. (1999) Methylglyoxal modification of protein: chemical and immunochemical characterization of methylglyoxal-arginine adducts. J. Biol. Chem. 274, 18492-18502
27. Kaplan, B., German, G., Ravid, M. and Pras, M. (1994) Determination of amyloid type by ELISA using milligram amounts of tissue. Clin. Chim. Acta 229, 171-179
28. Cordeiro, C. A. and Freire, A. P. (1994) Protein determination in permeabilized yeast cells using the Coomassie brilliant blue dye binding assay. Anal. Biochem. 223, 321-323
29. Kellum, M. W., Oray, B. and Norton, S. J. (1978) A convenient quantitative synthesis of methylglyoxal for glyoxalase I assays. Anal. Biochem. 85, 586-590
30. ε-(1-carboxyethyl)lysine-modified albumin. Biochem. J. 364, 1-14
31. Damas, A., Sebastião, M., Domingues, F., Costa, P. and Saraiva, M. J. (1995) Structural studies on FAP fibrils; removal of contaminants is essential for the interpretation of X-ray data. Amyloid 2, 173-178
32. Ahmed, N., Thornalley, R. J., Dawczynski, J., Franke, S., Strobel, J., Stein, G. and Haik, G. M. (2003) Methylglyoxal-derived hydroimidazolone advanced glycation end-products of human lens proteins. Invest. Ophthalmol. Vis. Sci. 44, 5287-5292
33. Lyons, T. J., Silvestri, G., Dunn, J. A., Dyer, D. G. and Baynes, J. W. (1991) Role of glycation in modification of lens crystallins in diabetic and nondiabetic senile cataracts. Diabetes 40, 1010-1015
34. Tanaka, N., Yonekura, H., Yamagishi, S., Fujimori, H., Yamamoto, Y. and Yamamoto, H. (2000) The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-α through nuclear factor-κB, and by 17 β-estradiol through Sp-1 in human vascular endothelial cells. J. Biol. Chem. 275, 25781-25790
35. Miyata, T., van Ypersele de Strihou, C., Kurokawa, K. and Baynes, J. W. (1999) Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications. Kidney Int. 55, 389-399
36. Kume, S., Takeya, M., Mori, T., Araki, N., Suzuki, H., Horiuchi, S., Kodama, T., Miyauchi, Y. and Takahashi, K. (1995) Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody. Am. J. Pathol. 147, 654-667
37. Castellani, R., Smith, M. A., Richey, P. L. and Perry, G. (1996) Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain Res. 737, 195-200
38. Quintas, A., Saraiva, M. J. and Brito, R. M. (1999) The tetrameric protein transthyretin dissociates to a non-native monomer in solution: a novel model for amyloidogenesis. J. Biol. Chem. 274, 32943-32949
39. Sousa, M. M., Cardoso, I., Fernandes, R., Guimaraes, A. and Saraiva, M. J. (2001) Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates. Am. J. Pathol. 159, 1993-2000
40. Sousa, M. M., Fernandes, R., Palha, J. A., Taboada, A., Vieira, P. and Saraiva, M. J. (2002) Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro. Am. J. Pathol. 161, 1935-1948
41. Bouma, B., Kroon-Batenburg, L. M., Wu, Y. P., Brunjes, B., Posthuma, G., Kranenburg, O., de Groot, P. G., Voest, E. E. and Gebbink, M. F. (2003) Glycation induces formation of amyloid cross-β structure in albumin. J. Biol. Chem. 278, 41810-41819
42. Quintas, A., Vaz, D. C., Cardoso, I., Saraiva, M. J. and Brito, R. M. (2001) Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants. J. Biol. Chem. 276, 27207-27213
43. Beckmann, J. S., Ye, Y. Z., Anderson, P. G., Chen, J., Accavitti, M. A., Tarpey, M. M. and White, C. R. (1994) Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol. Chem. Hoppe Seyler 375, 81-88
44. Andersson, K., Olofsson, A., Nielsen, E. H., Svehag, S. E. and Lundgren, E. (2002) Only amyloidogenic intermediates of transthyretin induce apoptosis. Biochem. Biophys. Res. Commun. 294, 309-314
45. Dickson, D. W. (2004) Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect? J. Clin. Invest. 114, 23-27
46. Yim, H. S., Kang, S. O., Hah, Y C., Chock, P. B. and Yim, M. B. (1995) Free radicals generated during the glycation reaction of amino acids by methylglyoxal: a model study of protein-cross-linked free radicals. J. Biol. Chem. 270, 28228-28233
47. Huttunen, H. J., Fages, C. and Rauvala, H. (1999) Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-κB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J. Biol. Chem. 274, 19919-19924
48. Nyhlin, N., Ando, Y., Nagai, R., Suhr, O., El Sahly, M., Terazaki, H., Yamashita, T., Ando, M. and Horiuchi, S. (2000) Advanced glycation end product in familial amyloidotic polyneuropathy (FAP). J. Int. Med. 247, 485-492
49. Hamilton, J. A., Steinrauf, L. K., Braden, B. C., Liepnieks, J., Benson, M. D., Holmgren, G., Sandgren, O. and Steen, L. (1993) The x-ray crystal structure refinements of normal human transthyretin and the amyloidogenic Val-30→ Met variant to 1.7-Å resolution. J. Biol. Chem. 268, 2416-2424
50. Sebastiao, M. P., Saraiva, M. J. and Damas, A. M. (1998) The crystal structure of amyloidogenic Leu55 → Pro transthyretin variant reveals a possible pathway for transthyretin polymerization into amyloid fibrils. J. Biol. Chem. 273, 24715-24722
51. Redondo, C., Damas, A. M., Olofsson, A., Lundgren, E. and Saraiva, M. J. (2000) Search for intermediate structures in transthyretin fibrillogenesis: soluble tetrameric Tyr78Phe TTR expresses a specific epitope present only in amyloid fibrils. J. Mol. Biol. 304, 461-470